vimarsana.com
Home
Live Updates
CVS Health Hold Rating Justified by Guidance Reduction and U
CVS Health Hold Rating Justified by Guidance Reduction and U
CVS Health Hold Rating Justified by Guidance Reduction and Uncertain Cost Trends
Analyst Steve Baxter of Wells Fargo maintained a Hold rating on CVS Health (CVS – Research Report), retaining the price target of $76.00. ...
Related Keywords
Steve Baxter ,
Wells Fargo ,
Barclays ,
Analyst Steve Baxter ,
Research Report ,
Medicare Advantage ,
Tipranks Premium ,